Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 6
150
Views
93
CrossRef citations to date
0
Altmetric
Research Article

Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum

, , , &
Pages 609-617 | Published online: 22 Sep 2008

References

  • ANDERSON, R. J. and WEINSHILBOUM, R. M., 1980, Phenolsulphotransfera in human tissue: radio-chemical enzymatic assay and biochemical properties. Clinica et Chimica Acta, 103,79–90.
  • ANON., 1998, Drug Data Handbook, 3rd edn (Auckland: Adis International), pp. 6–48.
  • BENET, L. Z., SVEIN, O. and SCHWARTZ, J. B., 1996, Design and optimization of dosage regimens, pharmacokinetic data. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon and A. G. Gilman (eds), The Pharmacological Basis of Therapeutics, 9th edn (New York: McGraw-Hill), pp. 1707–1793.
  • BOKKENHEUSER, V. D., SHACKLETON, C. H. L. and WINTER, J., 1987, Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochemical Pharmacology, 248, 953–956.
  • BONHAM CARTER, S. M., REIN, G., GLOVER, V. and SANDLER, M., 1983, Human platelet phenol-sulphotransfera M and P: substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide. British Journal of Clinical Pharmacology, 15, 323–330.
  • CAMPBELL, N. R. C., VAN LOON, J. A., SUNDARAM, R. S., AMES, M. M., HANSCH, C. and WEINSHILBOUM R., 1987, Human and rat liver phenol sulfotransfera: structure-activity relationships for phenolic substrates. Molecular Pharmacology, 32, 813–819.
  • CAPPIELLO, M., GIULIANI, L. and PACIF IC I, G. M., 1990, Differential distribution of phenol and catechol sulphotransfera in human liver and intestinal mucosa. Pharmacology, 40, 69–76.
  • CARBO, N., COSTELLI, P., BACCINO, F. M., LOPEZ-SORIANO, F. J. and ARGILES, J. M., 1999, Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochemical and Biophysical Research Communications, 254, 739–743.
  • CHEN, C. K. and PACE-ASCIAK, C. R., 1996, Vasorelaxing activity of resveratrol and quercitin in isolated rat aorta. General Pharmacology, 27, 363–366.
  • EATON, E. A., WALLE, U. K., LEWIS A. J., HUDSON, T., WILSON A. A. and WALLE, T., 1996, Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Drug Metabolism and Disposition, 24, 232–237.
  • FERRERO, M. E., BERTELLI, A. E., FULGENZI, A., PELLEGATTA, F., CORSI, M. M., BONFRATE, M., FERRARA, F., DE CATERINA, R., GIOVANNINI, L. and BERTELLI, A., 1998, Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. American Journal of Clinical Nutrition, 68, 1208–1214.
  • FOLDES, A. and MEEK, J., 1973, Rat brain phenolsulphotransferase-partial purification and some properties. Biochimica et Biophysica Acta, 327, 365–374.
  • GEHM, B. D., MCANDREWS, J. M., CHIEN, P. Y. and JAMESON, J. L., 1997, Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proceedings of the National Academy of Sciences, USA, 94, 14138–14143.
  • GOLDBERG, D. M., TSANG, E., KRARUMANCHIRI, A., DIAMANDIS, E. P., SOLEAS, G. and NG, E., 1996, Method to assay the concentrations of phenolic constituents of biological interest in wines. Analytical Chemistry, 68, 1688–1694.
  • GOLDBERG, D. M., YAN, Y., NG, E., DIAMANDIS, E. P., KARUMANCHIRI, A., SOLEAS, G. and WATERHOUSE, A. L. A., 1995, A global survey of transresveratrd concentrations in commercial wines. American Journal of Ecology and Viticulture, 44, 159–165.
  • HERTOG, M. G. L., HOLLMAN P. C. H., KATAN, M. B. and KROMHOUT, D., 1993, Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutrition and Cancer, 20, 21–29.
  • HSIEH, T. C. and Wu, J. M., 1999, Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Experimental Cell Research, 249, 109–115.
  • KUHNAU, J., 1976, A class of semi-essential food components: their role in human nutrition. World Review of Nutrition, 24, 117–191.
  • JAGER, U. and NGUYEN-DUONG, H., 1999, Relaxant effect of transresveratrol on isolated porcine coronary arteries. Arzneimittelforschung, 49, 207–211.
  • JEANDET, P., BESSIS, R. and GAUTHERON, B., 1991, The production of resveratrol (3,5,4'-trihydroxystilbene) by grape berries in different developmental stages. American Journal of Ecology and Viticulture, 42, 41–47.
  • JEANDET, P., BESSIS, R., MAUME B. F. and SBAGHI, M., 1993, Analysis of resveratrol in Burgundy wines. Journal of Wine Research, 4,79–85.
  • LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. and RANDALL, R. J., 1951, Protein measurement with Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
  • MGBONYEBI, O. P., Russo, J. and Russo, I. H., 1998, Antiproliferative effect of synthetic resveratrol on human breast epithelial cell. Intern ationd Journal of Oncology, 12, 865–869.
  • NEUVONEN, P. J. and KIVISTO, K. T., 1988, Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids. European Journal of Clinical Pharmacology, 35, 495–501.
  • PACIFICI, G. M. and DE SANTI, C., 1995, Human sulphotransferase. Classification and metabolic profile of the major isoforms. The point of view of the clinical pharmacologist. In G. M. Pacifici and G. N. Fracchia (eds), Advanced in Drug Metabolism in Man (Luxembourg: European Commission), pp. 311–349.
  • PACIFICI, G. M. and VIANI, A., 1992, Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clinical Pharmacokinetics, 23, 449–468.
  • PENDURTHI, U. R., WILLIAMS, J. T. and RAO, L. V., 1999, Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arteriosclerosis and Thrombosis Vascular Biology, 19, 419–426.
  • RAFTOGIANIS, R. B., HER, C. and WEINSHILBOUM, R. M., 1996, Human phenol sulfotransferase pharmacogenetics : STP1* gene cloning and structural characterization. Pharmacogenetics, 6, 473–478.
  • SUNDARAM, R. S., SZUMLANSKI, C., OTTERNESS, D., VAN LOON, J. A. and WEINSHILBOUM, R. M., 1989, Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form. Drug Metabolism and Disposition, 17, 255–264.
  • VIETRI, M., DE SANTI, C., PIETRABISSA, A., MOSCA, F. and PACIFICI, G. M., 2000a, Inhibition of human liver phenol sulfotransfera by nonsteroidal antiinfiammatory drugs. European Journal of Clinical Pharmacology (in press).
  • VIETRI, M., DE SANTI, C., PIETRABISSA, A., MOSCA F. and PACIFICI, G. M., 2000b, Fenamates are potent inhibitors of human liver phenol sulfotransferase Xenobiotka (in press).
  • WEINSHILBOUM, R. M., 1986, Phenol sulphotransfera in humans: properties, regulation, and function. Federation Proceedings, 45, 2223–2228.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.